Credit Suisse Ag Tricida, Inc. Transaction History

Credit Suisse Ag

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.14 - $12.49 $18,420 - $1.64 Million	131,575 Added 660.38%	151,499 $22,000
Q3 2022 Nov 10, 2022	BUY	$8.51 - $13.6 $1,455 - $2,325	171 Added 0.87%	19,924 $209,000
Q2 2022 Aug 12, 2022	BUY	$7.31 - $11.85 $144,394 - $234,073	19,753 New	19,753 $192,000
Q4 2021 Feb 14, 2022	SELL	$4.19 - $9.56 $89,544 - $204,306	-21,371 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$3.56 - $4.64 $5,578 - $7,270	-1,567 Reduced 6.83%	21,371 $99,000

Q2 2021 Aug 16, 2021	SELL	$3.95 - $5.41 $73,628 - $100,842	-18,640 Reduced 44.83%	22,938 $99,000
Q1 2021 May 14, 2021	SELL	$4.52 - $7.8 $198,229 - $342,076	-43,856 Reduced 51.33%	41,578 $220,000
Q4 2020 Feb 12, 2021	BUY	$4.37 - $9.46 $163,022 - $352,905	37,305 Added 77.51%	85,434 $602,000
Q3 2020 Nov 13, 2020	BUY	$8.56 - $26.93 $209,377 - $658,707	24,460 Added 103.34%	48,129 $436,000
Q2 2020 Aug 12, 2020	BUY	$21.21 - $31.55 $117,545 - $174,850	5,542 Added 30.57%	23,669 $650,000
Q1 2020 May 13, 2020	SELL	$18.43 - $38.04 $519,836 - $1.07 Million	-28,206 Reduced 60.88%	18,127 $399,000
Q4 2019 Feb 12, 2020	BUY	$29.6 - $43.71 $989,113 - $1.46 Million	33,416 Added 258.7%	46,333 $1.75 Million
Q3 2019 Nov 12, 2019	BUY	$29.87 - $42.22 $101,319 - $143,210	3,392 Added 35.61%	12,917 $399,000
Q2 2019 Aug 14, 2019	BUY	$31.16 - $39.46 $3,116 - $3,946	100 Added 1.06%	9,525 $376,000
Q1 2019 May 14, 2019	BUY	$19.96 - $38.62 $188,123 - $363,993	9,425 New	9,425 $364,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.